NCT05668481

Brief Summary

The main empirical question to be addressed is: What types of memory support are most potent for patients who are experiencing a mild cognitive impairment (MCI) relative to non-MCI patients?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
119

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 29, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

May 19, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2025

Completed
Last Updated

July 20, 2025

Status Verified

July 1, 2025

Enrollment Period

2.1 years

First QC Date

December 12, 2022

Last Update Submit

July 16, 2025

Conditions

Keywords

mild cognitive impairmentsleep and circadian functioningimproving treatment outcome

Outcome Measures

Primary Outcomes (6)

  • Number of items recalled on the free recall task to assess outcome for constructive memory support

    Assesses patient memory for treatment

    Delivered two times: At the session in which constructive memory supports were used (baseline) and 1 week later.

  • Number of items recalled on the free recall task to assess outcome for non-constructive memory support

    Assesses patient memory for treatment

    Delivered two times: At the end of the session in which non-constructive memory supports were used (baseline) and 1 week later.

  • Number and accuracy of thoughts about the material covered in the prior treatment session in which constructive memory supports were delivered

    To assess if the participant thought about the therapy session and if the thoughts accurately reflected the prior treatment session

    Delivered once: At the beginning of the session held 1 week after the delivery of the constructive memory supports

  • Number and accuracy of thoughts about the material covered in the prior treatment session in which non-constructive memory supports were delivered

    To assess if the participant thought about the therapy session and if the thoughts accurately reflected the prior treatment session

    Delivered once: At the beginning of the session held 1 week after the delivery of the non-constructive memory supports

  • Number and accuracy of applications of the material covered in the prior treatment session in which constructive memory supports were delivered

    To assess if the participant applied the material covered in the therapy session and if the participant accurately applied the material prior treatment session

    Delivered once: At the beginning of the session held 1 week after the delivery of the constructive memory supports

  • Number and accuracy of applications of the material covered in the prior treatment session in which non-constructive memory supports were delivered

    To assess if the participant applied the material covered in the therapy session and if the participant accurately applied the material prior treatment session

    Delivered once: At the beginning of the session held 1 week after the delivery of the non-constructive memory supports

Secondary Outcomes (1)

  • Acceptability of constructive memory support

    One time point: At the end of the treatment session in which constructive memory support was delivered

Other Outcomes (8)

  • PROMIS-Sleep Disturbance

    At baseline

  • PROMIS-Sleep-related impairment

    At baseline

  • British Columbia Cognitive Complaints Inventory

    At baseline

  • +5 more other outcomes

Study Arms (2)

Constructive memory support

ACTIVE COMPARATOR

Participants will watch videos of a sleep expert delivering treatment components from the Transdiagnostic Sleep and Circadian Intervention (TranS-C). After each video, a team member will deliver constructive memory supports.

Behavioral: Transdiagnostic sleep and circadian intervention (TranS-C)

Non-constructive memory support

ACTIVE COMPARATOR

Participants will watch videos of a sleep expert delivering treatment components from the Transdiagnostic Sleep and Circadian Intervention (TranS-C). After each video, a team member will deliver non-constructive memory supports.

Behavioral: Transdiagnostic sleep and circadian intervention (TranS-C)

Interventions

TranS-C is a psychosocial treatment that helps people who have sleep and circadian problems to improve their sleep health.

Constructive memory supportNon-constructive memory support

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants 60 years and older will be recruited.
  • Fluent in English.
  • Experiencing some difficulties relating to sleep and circadian functioning and (d) a score of 19-25 on the Montreal Cognitive Assessment (for the MCI group) and score 26-30 on the Montreal Cognitive Assessment (for the non-MCI group) (e) Have a computer to use and an internet connection and (f) be able to attend sessions weekly and on the same day each week.

You may not qualify if:

  • Presence of an active and progressive mental or physical illness or neurological degenerative disease;
  • Night shift work \>2 nights per week in the past 3 months;
  • Not able and willing to participate in and/or complete the assessments and participate in the treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Berkeley

Berkeley, California, 94720-1650, United States

Location

MeSH Terms

Conditions

Memory DisordersSleep Wake DisordersCognitive Dysfunction

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersCognition DisordersNeurocognitive Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not be aware that they are receiving constructive memory support in one session and non-constructive memory support in the next session
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Participants will be randomized to receive constructive memory supports in Session 1 OR to receive non-constructive memory supports in Session 1. In Session 2, participants will receive the type of memory support they did not receive in Session 1. In other words, if a participant received constructive memory support in Session 1, in Session 2 they will receive non-constructive memory support. And if a participant received non-constructive memory support in Session 1, in Session 2 they will receive constructive memory support. This cross-over design was adopted to increase the number of observations of the constructive and non-constructive memory support.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2022

First Posted

December 29, 2022

Study Start

May 19, 2023

Primary Completion

June 26, 2025

Study Completion

June 26, 2025

Last Updated

July 20, 2025

Record last verified: 2025-07

Locations